title: Natural killer T cells and rheumatoid arthritis: friend or foe?
authors.affiliation: Laboratory for Molecular Immunology and Inflammation, Division of Rheumatology, Ghent University Hospital, Belgium. dirk.elewaut@ugent.be
authors.forename: Dirk
authors.initials: D
authors.lastname: Elewaut
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D001169:Arthritis, Experimental / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000628:therapy; D001172:Arthritis, Rheumatoid / Q000276:immunology* / Q000628:therapy; D001327:Autoimmune Diseases / Q000276:immunology* / Q000628:therapy; D016207:Cytokines / Q000502:physiology; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D005699:Galactosylceramides / Q000494:pharmacology / Q000627:therapeutic use; D006017:Glycolipids / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D016219:Immunotherapy, Adoptive; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology* / Q000637:transplantation; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D008810:Mice, Inbred C57BL; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000032:analysis; D018040:Receptors, Neurokinin-1 / Q000032:analysis; D016176:T-Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology* / Q000637:transplantation; D016212:Transforming Growth Factor beta / Q000502:physiology; D053773:Transforming Growth Factor beta1
chemical_list: D000276:Adjuvants, Immunologic; D016207:Cytokines; D005699:Galactosylceramides; D006017:Glycolipids; D016693:Receptors, Antigen, T-Cell, alpha-beta; D018040:Receptors, Neurokinin-1; C508960:TGFB1 protein, human; C508961:Tgfb1 protein, mouse; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; C493154:alpha-galactosylceramide; C501055:tetracosanoic acid 1-galactopyranosyloxy-3,4-dihydroxydec-2-yl amide
references.citation: Nature. 1998 Jan 8;391(6663):177-81
references.pmid: 9428763
references.citation: Eur J Immunol. 1997 May;27(5):1213-20
references.pmid: 9174613
references.citation: Immunogenetics. 1999 Nov;50(3-4):146-51
references.pmid: 10602876
references.citation: Immunol Today. 2000 Nov;21(11):573-83
references.pmid: 11094262
references.citation: Semin Immunol. 2000 Dec;12(6):561-8
references.pmid: 11145862
references.citation: Arthritis Rheum. 2001 May;44(5):1127-38
references.pmid: 11352245
references.citation: Nat Med. 2001 Sep;7(9):1052-6
references.pmid: 11533710
references.citation: Nature. 2001 Oct 4;413(6855):531-4
references.pmid: 11586362
references.citation: Nat Immunol. 2002 Apr;3(4):360-5
references.pmid: 11896391
references.citation: J Clin Invest. 2002 Sep;110(6):793-800
references.pmid: 12235110
references.citation: Clin Cancer Res. 2002 Dec;8(12):3702-9
references.pmid: 12473579
references.citation: Curr Opin Immunol. 2003 Dec;15(6):683-9
references.pmid: 14630203
references.citation: Arthritis Rheum. 2004 Jan;50(1):305-13
references.pmid: 14730629
references.citation: Oncol Res. 1995;7(10-11):529-34
references.pmid: 8866665
references.citation: J Exp Med. 2005 Jan 3;201(1):41-7
references.pmid: 15630137